Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Treatment of Resistant Langerhans Cell Histiocytosis With ENBREL
This study has been completed.
Study NCT00048373 Information provided by Baylor College of Medicine
First Received: October 30, 2002 Last Updated: August 22, 2006
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Histiocytosis, Langerhans-Cell
Additional conditions recognized in this trial
Histiocytosis
More general conditions related to this trial
Lung Diseases
Lung Diseases, Interstitial
Lymphatic Diseases
Respiratory Tract Diseases
Reticuloendotheliosis
Interventions listed in this trial
Etanercept
Additional drug interventions recognized in this trial
TNFR-Fc fusion protein
More general drug interventions related to this trial
Analgesics
Analgesics, Non-Narcotic
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Antirheumatic Agents
Central Nervous System Agents
Gastrointestinal Agents
Immunologic Factors
Immunosuppressive Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
Baylor College of Medicine
Texas Children's Hospital
The Methodist Hospital System
Back to top of Main Content
